Tolsura Capsule, Gelatin Coated
Product Images NDC 51862-462

2 FDA label images from Mayne Pharma Commercial Llc · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Tolsura (NDC 51862-462). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Mayne Pharma Commercial Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Tolsura 01)

Chemical Structure (Tolsura 01)
Chemical structure of Itraconazole, the active ingredient in Tolsura 65 mg gelatin-coated capsules by Mayne Pharma Commercial LLC. The diagram shows the molecular formula with various aromatic rings and heterocyclic components.*
FDA Label Image

Principal Display Panel (65 mg Capsule Bottle Label)

Principal Display Panel (65 mg Capsule Bottle Label)
Packaging label for Tolsura (Itraconazole Capsules) 65 mg by Mayne Pharma Commercial LLC. The label shows the product strength of 65 mg per capsule, the NDC number 51862-462-60, and the quantity of 60 capsules. It includes storage instructions, a caution that Tolsura is not interchangeable on a mg per mg basis with other itraconazole formulations, and the manufacturer's location in Greenville, NC, with the product made in Spain.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.